VectivBio (VECT) Institutional Ownership → get a piece of the profit from this land (From True Market Insiders) (Ad) Free VECT Stock Alerts $16.85 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for VectivBio (NASDAQ:VECT)Number ofInstitutional Buyers(last 12 months)17TotalInstitutional Inflows(last 12 months)$103.99MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$41.85M Get VECT Insider Trade Alerts Want to know when executives and insiders are buying or selling VectivBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VECT Institutional Buying and Selling by Quarter Ad InvestorPlaceHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs VectivBio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/23/2024 Regency Capital Management Inc. DE510,000$8.59M5.5%+1,600.0%0.000% 8/22/2023CHI Advisors LLC2,782,756$46.95M14.2%-47.1%0.000% 8/14/2023Ergoteles LLC443,928$7.49M0.4%N/A0.000% 8/14/2023 EHP Funds Inc.170,000$2.87M0.7%N/A0.000% 8/14/2023 Hunting Hill Global Capital LLC63,581$1.07M0.3%N/A0.000% 8/14/2023 Prelude Capital Management LLC219,643$3.71M0.2%N/A0.000% Get the Latest News and Ratings for VECT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VectivBio and its competitors with MarketBeat's FREE daily newsletter. 8/14/2023 Chicago Capital Management LLC173,840$2.96M3.8%N/A0.000% 8/11/2023 Hsbc Holdings PLC562,022$9.48M0.0%N/A0.000% 8/10/2023 Gardner Lewis Asset Management L P642,769$10.84M3.9%N/A1.889% 8/10/2023 Alpine Associates Management Inc.1,806,697$30.71M1.4%N/A5.311% 8/7/2023 Wolverine Asset Management LLC33,426$564K0.0%N/A0.000% 8/7/2023 Versor Investments LP1,210,379$20.42M3.5%N/A0.000% 8/7/2023 New York Life Investment Management LLC135,051$2.28M0.0%N/A0.000% 8/3/2023 Picton Mahoney Asset Management100,000$1.70M0.1%N/A0.000% 8/1/2023 Regency Capital Management Inc. DE30,000$506K0.4%-21.1%0.000% 7/27/2023Virtu Financial LLC41,411$699K0.1%N/A0.000% 7/27/2023 GAM Holding AG27,545$465K0.0%N/A0.000% 7/20/2023 Harvest Management LLC45,817$779K0.7%N/A0.135% 7/20/2023 Exchange Traded Concepts LLC8,512$144K0.0%N/A0.000% 5/11/2023CHI Advisors LLC5,255,484$44.72M11.9%-4.3%0.000% 5/10/2023Tekla Capital Management LLC682,834$5.87M0.2%-7.4%0.000% 5/8/2023 Regency Capital Management Inc. DE38,000$323K0.4%N/A0.000% 2/14/2023 VR Adviser LLC1,866,000$16.17M2.6%N/A5.487% 2/14/2023 Driehaus Capital Management LLC1,716,656$14.78M0.2%+100.8%5.048% 2/13/2023 Vivo Capital LLC2,333,300$20.22M2.3%N/A6.861% 2/10/2023Tekla Capital Management LLC737,704$6.35M0.2%-2.5%2.169% 2/8/2023 UBS Group AG253,877$2.20M0.0%-2.4%0.746% 2/3/2023 Frazier Life Sciences Management L.P.1,333,400$11.48M0.7%N/A3.920% 11/15/2022 Citadel Advisors LLC3,145,251$18.87M0.0%+0.1%9.248% 11/14/2022 Cormorant Asset Management LP2,536,617$15.22M1.1%-10.7%7.457% 11/14/2022 Caxton Corp140,863$845K1.6%-27.6%0.414% 11/3/2022 Barclays PLC7,807$47K0.0%N/A0.023% 10/13/2022 National Bank of Canada FI165,333$992K0.0%N/A0.486% 8/16/2022 Driehaus Capital Management LLC865,229$4.67M0.1%+120.0%2.544% 8/15/2022 Caxton Corp194,577$1.05M1.4%N/A0.572% 2/3/2022 Canaan Partners XI LLC37,051$182K0.0%N/A0.109% 11/16/2021CHI Advisors LLC2,592,602$20.03M5.8%+0.3%7.622% 11/16/2021 Citadel Advisors LLC2,721,363$20.73M0.0%-0.2%8.000% 11/15/2021 Caas Capital Management LP22,565$174K0.0%-45.1%0.066% 8/17/2021 Woodline Partners LP86,596$1.01M0.0%N/A0.255% Elon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake.8/17/2021 Millennium Management LLC95,214$1.11M0.0%N/A0.280% 8/17/2021 PFM Health Sciences LP611,074$7.13M0.2%N/A1.796% 8/17/2021 Caas Capital Management LP41,096$479K0.0%N/A0.121% 8/17/2021 Citadel Advisors LLC2,725,767$31.24M0.0%N/A8.013% 8/16/2021 Squarepoint Ops LLC25,000$292K0.0%N/A0.073% 8/16/2021Pinz Capital Management LP30,561$356K0.1%N/A0.090% 8/13/2021 Northern Trust Corp7,159$83K0.0%N/A0.021% 8/13/2021Tekla Capital Management LLC145,000$1.69M0.1%N/A0.426% 8/13/2021 Geode Capital Management LLC17,780$207K0.0%N/A0.052% 8/12/2021 Monashee Investment Management LLC54,466$635K0.1%N/A0.160% 8/11/2021CHI Advisors LLC2,585,986$30.15M7.0%N/A7.602% (Data available from 1/1/2016 forward) VECT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VECT shares? During the previous two years, 29 institutional investors and hedge funds held shares of VectivBio. The most heavily invested institutionals were CHI Advisors LLC ($46.95M), Alpine Associates Management Inc. ($30.71M), Versor Investments LP ($20.42M), Vivo Capital LLC ($20.22M), Citadel Advisors LLC ($18.87M), VR Adviser LLC ($16.17M), and Cormorant Asset Management LP ($15.22M).Learn more on VECT's institutional investors. Which institutional investors have been buying VectivBio stock? Of the 25 institutional investors that purchased VectivBio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($2.33M), VR Adviser LLC ($1.87M), Alpine Associates Management Inc. ($1.81M), Driehaus Capital Management LLC ($1.33M), Frazier Life Sciences Management L.P. ($1.33M), Versor Investments LP ($1.21M), and Gardner Lewis Asset Management L P ($642.77K). How much institutional buying is happening at VectivBio? Institutional investors have bought a total of 13,438,837 shares in the last 24 months. This purchase volume represents approximately $164.37M in transactions. Which VectivBio major shareholders have been selling company stock? The following institutional investors have sold VectivBio stock in the last 24 months: CHI Advisors LLC ($2.71M), Cormorant Asset Management LP ($303.77K), Tekla Capital Management LLC ($73.67K), Caxton Corp ($53.71K), Regency Capital Management Inc. DE ($8K), and UBS Group AG ($6.29K). How much institutional selling is happening at VectivBio? Institutional investors have sold a total of 3,155,581 shares in the last 24 months. This volume of shares sold represents approximately $46.70M in transactions. Related Companies: ALVO Major Shareholders DRTSW Major Shareholders AONC Major Shareholders BCTXW Major Shareholders BTSGU Major Shareholders BFRGW Major Shareholders CELUW Major Shareholders This page (NASDAQ:VECT) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss RatingsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VectivBio Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.